Nabriva Therapeutics (NASDAQ:NBRV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Stock Performance NBRV opened at $0.00 on Thursday. Nabriva Therapeutics has a one year low of $1.22 and a one year high […]
More Stories
Mechanics Bank Trust Department Sells 1,210 Shares of The Boeing Company (NYSE:BA)
Mechanics Bank Trust Department cut its holdings in shares of The Boeing Company (NYSE:BA – Free Report) by 13.4% during...
JPMorgan Chase & Co. (NYSE:JPM) Shares Acquired by Brown Miller Wealth Management LLC
Brown Miller Wealth Management LLC lifted its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 0.4% during the 3rd quarter,...
Matrix Asset Advisors Inc. NY Buys 4,897 Shares of iShares Russell Mid-Cap ETF (NYSEARCA:IWR)
Matrix Asset Advisors Inc. NY boosted its stake in shares of iShares Russell Mid-Cap ETF (NYSEARCA:IWR – Free Report) by...
Matrix Asset Advisors Inc. NY Makes New $248,000 Investment in International Business Machines Co. (NYSE:IBM)
Matrix Asset Advisors Inc. NY acquired a new position in shares of International Business Machines Co. (NYSE:IBM – Free Report)...
Fiduciary Financial Group LLC Acquires 4,335 Shares of The AES Co. (NYSE:AES)
Fiduciary Financial Group LLC raised its holdings in shares of The AES Co. (NYSE:AES – Free Report) by 32.1% in...
Valeura Energy (LON:VLU) Trading Down 0.3% – What’s Next?
Valeura Energy Inc. (LON:VLU – Get Free Report)’s stock price traded down 0.3% during trading on Friday . The company...